Gilead’s Generics Steal Market Share from Abbvie’s Mavyret

Sara White, Doctor of Pharmacy, Masters in Public Health and is the resident expert on drug pricing, generics and healthcare accessibility. The following articles covers the release of new hep C generics from two large pharmaceutical companies fighting for the HCV market share in the US. First article is authored by Sara White, the second …

Gilead’s Generics Steal Market Share from Abbvie’s Mavyret Read More »